Accomplished Global Pharma Executive Mary Oates Joins Lachman Consultants, Inc. as VP of Compliance Services
Fran Zipp, President and CEO of Lachman Consultants, Inc. a leading provider of compliance, regulatory affairs, and technical services to global life sciences organizations, today announced that Mary Oates has joined the firm as Vice President of Compliance Services.
WESTBURY, N.Y., April 2, 2019 /PRNewswire-PRWeb/ -- In her role, Oates will lead the expert team that comprises Lachman's Compliance Practice Group, bringing a unique client-side perspective on a broad range of compliance matters to the firm's international clientele.
Oates' path is one of marked by a series of ascending leadership roles since she began her career as a Senior Scientist for Glaxo Inc. in 1990. In 1994, she joined Warner Lambert, moving up as Director of the Quality Design Department. When Warner Lambert was acquired by Pfizer Inc. in 2000, Oates remained with the organization, taking on leadership positions of increasing responsibility in Quality and Regulatory Affairs over the next 18 years. This culminated in her appointment as the head of Global Quality Operations and as the Vice President of Innovative Operations and Network Excellence. In this capacity, Oates was responsible for the supply of all consumer healthcare products, internal biological manufacturing and global implementation of lean manufacturing across the Pfizer network. Her career with Pfizer has been one marked by consistent and significant accomplishment, as she helped the organization achieve high levels of quality performance across over 60 facilities around the world.
"It is exciting to add someone to our team who has managed quality and compliance for one of the world's largest pharmaceutical organizations," commented Zipp. "I've known Mary for many years, and her record of achievement speaks for itself. As a vocal advocate of driving excellence in quality systems, processes and cultures, she has always kept the betterment of the patient in mind. In addition to a broad range of experiences, her client-side perspective will give our clients a measure of added assurance.
Oates has been an active participant at industry conferences and events throughout her career. She is an accomplished and sought-after speaker on the topics of quality, compliance and regulatory affairs. Oates is a board member of the Parenteral Drug Association, and a past member of the ICH Q12 Expert Working Group. She holds a B.S. in Biochemistry from Queens College, and a Ph.D. in Analytical Chemistry from the University of North Carolina at Chapel Hill.
During her career, Oates had the opportunity to work with Lachman Consultants on several occasions. "As a former Lachman client, I can attest to the high caliber of their consultants, the depth of expertise, and the value of their insights," she commented. "I'm excited to join this team and apply nearly 30 years of experience in fulfilling a personal mission of ensuring that patients everywhere receive the safe, quality medicines, devices and regimens they need."
ABOUT LACHMAN CONSULTANTS
Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which consistently exceed client requirements and expectations.
For additional press information, please contact:
Ilena Della Ventura
Delia Associates
T. 908-534-9044
E. [email protected]
SOURCE Delia Associates
Share this article